| Brawn Biotech Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 530207 |
NSE Symbol : - |
P/E(TTM) : 0.00 |
|
ISIN Demat : INE899B01015 |
Div & Yield% : 0.00 |
EPS(TTM) : 0.00 |
|
Book Value(₹) : 12.35 |
Market Cap(₹Cr) : 6.03 |
Face Value(₹) : 10.00 |
| Particulars | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|
| Gross Sales | 4.31 | 4.89 | 5.80 | 2.26 | 3.84 | 3.30 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 4.31 | 4.89 | 5.80 | 2.26 | 3.84 | 3.30 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 0.09 | 0.09 | 0.09 | 0.09 | 0.00 | 0.00 |
| Total Income | 4.40 | 4.98 | 5.89 | 2.35 | 3.85 | 3.30 |
| Total Expenditure | 4.32 | 4.88 | 5.62 | 2.81 | 4.25 | 3.61 |
| PBIDT | 0.08 | 0.10 | 0.27 | -0.46 | -0.40 | -0.32 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBDT | 0.08 | 0.10 | 0.27 | -0.46 | -0.40 | -0.32 |
| Depreciation | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 |
| Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Reported Profit After Tax | 0.05 | 0.07 | 0.24 | -0.49 | -0.43 | -0.34 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 0.05 | 0.07 | 0.24 | -0.49 | -0.43 | -0.34 |
| EPS (Unit Curr.) | 0.17 | 0.25 | 0.89 | -1.65 | -1.44 | -0.96 |
| EPS (Adj) (Unit Curr.) | 0.17 | 0.25 | 0.89 | -1.65 | -1.44 | -0.96 |
| Calculated EPS (Unit Curr.) | 0.17 | 0.24 | 0.79 | -1.65 | -1.44 | -1.15 |
| Calculated EPS (Adj) (Unit Curr.) | 0.17 | 0.24 | 0.79 | -1.65 | -1.44 | -1.15 |
| Calculated EPS (Ann.) (Unit Curr.) | 0.66 | 0.95 | 3.15 | -6.59 | -5.76 | -4.58 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 0.66 | 0.95 | 3.15 | -6.59 | -5.76 | -4.58 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 1.86 | 2.04 | 4.66 | -20.35 | -10.42 | -9.70 |
| PBDTM(%) | 1.86 | 2.04 | 4.66 | -20.35 | -10.42 | -9.70 |
| PATM(%) | 1.16 | 1.43 | 4.14 | -21.68 | -11.20 | -10.30 |
